Project Details
| Short title | Targeting the aldo-keto reductase AKR1C3 in haemato-lymphoid malignancy |
|---|---|
| Status | Finished |
| Effective start/end date | 1/10/10 → 31/08/14 |
Funding
- BLOODWISE
Targeting the aldo-keto reductase AKR1C3 in haemato-lymphoid malignancy
- Bunce, Christopher (Principal Investigator)
- Drayson, Mark (Co-Investigator)